Gender | |||
---|---|---|---|
Male | 19 | 66 % | |
Female | 10 | 33 % | |
Age at diagnosis | |||
18,1 | |||
median (min-max) | 19 | 8 – 65 | |
Age at initiation of treatment | |||
19 | |||
median (min-max) | 20 | 9 – 72 | |
≤18 years | 15 | 45 % | |
Histological subtype of osteosarcoma | |||
osteoblastic | 18 | 62 % | |
chondroblastic | 5 | 17 % | |
osteogenic | 3 | 10 % | |
telangiectasic | 2 | 7 % | |
pleiomorphic | 1 | 4 % | |
Tumor grade | |||
Grade III | 29 | 100 % | |
Stage at beginning of TT | |||
progression | 30 | 91 % | |
complete remission after relapse | 3 | 9 % | |
Localization of relapse | |||
localized | 0 | 0 % | |
metastatic | 24 | 73 % | |
both | 9 | 27 % | |
Number of previous treatment lines | |||
2,9 | |||
median (min-max) | 3 | 1 – 8 | |
0 | 0 | 0 % | |
1 | 4 | 12 % | |
2 | 12 | 36 % | |
3 | 10 | 30 % | |
≥4 | 7 | 21 % | |
Delay diagnosis - initiation of TT | |||
2,8 years | |||
median (min-max) | 2,7 years | (0,6 – 7 years) |